Combined deletion of cytosolic 5′-nucleotidases IA and II lowers glycemia by improving skeletal muscle insulin action and lowering hepatic glucose production
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.108295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Roxane Jacobs und 6 weiteren Autor:innen. Beteiligte Einrichtung: Université catholique de Louvain (UCLouvain) and de Duve Institute (DDUV), Brussels, Belgium. Hauptthemen laut MEDLINE: 5'-Nucleotidase, Muscle, Skeletal, Liver, Insulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund for Scientific Research.
Abstract (Originalsprache)
Obesity and type 2 diabetes (T2D)-linked hyperglycemia, along with their associated complications, have reached pandemic proportions, constituting a major public health issue. Genetic deletion or pharmacological inhibition of purine nucleotide-metabolizing enzymes has emerged as a potential strategy for treating diseases. We previously showed that cytosolic 5'-nucleotidase II (NT5C2)-deficient mice were protected against high-fat diet (HFD)-induced insulin resistance. This study investigated the effects of dual deletion of cytosolic 5'-nucleotidases IA (NT5C1A) and II (NT5C2) in mice. We found that NT5C1A/NT5C2 double-knockout (NT5C-dKO) mice exhibited mild hypoglycemia, associated with enhanced skeletal muscle insulin action and reduced hepatic glucose production. This phenotype was accompanied by liver and skeletal muscle proteomic alterations notably related to amino acid metabolism, besides the potential involvement of adenosine monophosphate (AMP)-activated protein kinase (AMPK). Our findings support the development of novel anti-diabetic treatments using small-molecule cytosolic 5'-nucleotidase inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université catholique de Louvain (UCLouvain) and de Duve Institute (DDUV), Brussels, Belgium.
- Université de Lille, Institut Pasteur de Lille and INSERM, Lille, France.
- Université catholique de Louvain (UCLouvain) and de Duve Institute (DDUV), Brussels, Belgium. Electronic address: manuel.johanns@uclouvain.be.
Förderung
- Fund for Scientific Research
Zitieren
APA
Jacobs, R., Herinckx, G., Galland, N., Balty, C., Vertommen, D., Rider, M. H., & Johanns, M. (2025). Combined deletion of cytosolic 5′-nucleotidases IA and II lowers glycemia by improving skeletal muscle insulin action and lowering hepatic glucose production. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108295
Vancouver
Jacobs R, Herinckx G, Galland N, Balty C, Vertommen D, Rider MH, et al. Combined deletion of cytosolic 5′-nucleotidases IA and II lowers glycemia by improving skeletal muscle insulin action and lowering hepatic glucose production. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108295
BibTeX
@article{Jacobs2025,
author = {Jacobs, Roxane and Herinckx, Gaëtan and Galland, Noémie and Balty, Clémence and Vertommen, Didier and Rider, Mark H and Johanns, Manuel},
title = {Combined deletion of cytosolic 5′-nucleotidases IA and II lowers glycemia by improving skeletal muscle insulin action and lowering hepatic glucose production},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.108295}
}
EUVIMED